17,261 trials
Plaque · Gingivitis
Primary: Safety and Tolerability of KSL-W as Measured by Soft Tissue Erythema, Ulceration and Sloughing (AEs and SAEs) — 2; 1; 4; 2 Participants
Venous Thromboembolism · Deep Venous Thrombosis · Pulmonary Embolus
Primary: Number of Participants With Venous Thromboembolism Events — 5; 0 Participants
Acute Lung Injury · Acute Respiratory Distress Syndrome · Respiratory Failure
Primary: Serum IL-6 Level — -0.79; -0.79 pg/mL
Infections, Streptococcal
Primary: Time to Occurrence of Any Acute Otitis Media (AOM) Diagnosed and Verified Against American Academic of Pediatrics (AAP) Criteria — 0.425; 0.442 Episodes per person-year…
Anaemia
Primary: Modeled Hemoglobin (Hgb) Change From Baseline (Pre-dose on Day 1) at 4 Weeks of Treatment — -1.130; -1.070; 0.212; -0.273 Grams per deciliter (g/dL) — p=0.0135
Cocaine Dependence
Primary: Average Number of Positive Urine Tests — 32; 30.2; 28.1; 31.4 urine tests
Non-Hodgkin's Lymphoma
Primary: Overall Survival and Progression Free Survival — 73 percentage of patients
Premature Ejaculation
Primary: Mean Intravaginal Ejaculatory Latency Time (IELT) Compared Over All 8 Weeks of Treatment or Until Premature Discontinuation — 0.62; 0.72; 0.69; 0.71 minutes — p=0.4959
Pathological Gambling
Primary: Yale Brown Obsessive Compulsive Scale Modified for Pathological Gambling (YBOCS-PG) — 16.0; 17.0; 10.0; 4.0 units on a scale
HER2-positive Breast Cancer · Stage II Breast Cancer · Stage IIIA Breast Cancer
Primary: Expression of ALDH1 and CD44v Change in the Binary Biomarkers From Baseline to 6 Weeks and 18 Weeks — 5; 3; 0; 4 Participants
Shigellosis
Primary: Post-challenge Diarrhea, Fever, and Blood in Stool Adverse Events by Study Group — 1; 0; 4; 4 participants
PCV · Polypoidal Choroidal Vasculopathy
Primary: BCVA — -3.50; 29.50; 8.60 number of letters read correctly
Cocaine Abuse
Primary: Cocaine Self-administration — 0; 1.5; 3; 4 Number of Choices
Pelvic Organ Prolapse
Primary: Number of Participants With Treatment Failure Defined as Subsequent Treatment for Urinary Incontinence, Signs or Symptoms of Bothersome Urinary Incontinence — 39; 85…
HIV · Cardiovascular Diseases · Inflammation
Primary: Percentage Platelet Aggregation in PRP After Stimulation With Arachidonic Acid 1600 μM for 5 Min — 72.35; 79.11; 72.79; 26.77 %aggregation